Biography
Dr. Chanock received his M.D. from Harvard Medical School in 1983 and completed clinical training in pediatrics, pediatric infectious diseases, and pediatric hematology/oncology and research training in molecular genetics at Boston Children’s Hospital and the Dana-Farber Cancer Institute, Boston. Afterwards, he joined the NCI Pediatric Oncology Branch where he eventually became a Senior Investigator. Initially, Dr. Chanock investigated the molecular, genetic, and clinical problems of infectious complications in patients with cancer and HIV infection. Beginning in the mid-1990s, Dr. Chanock shifted his interest towards investigating the contribution of germ-line genetic variation to cancer and its related outcomes. For five years, he served as Co-Chair of the NCI’s Genetics, Genomics and Proteomics Faculty. In 2001, he became director of the NCI Core Genotyping Facility and in 2005 he became co-leader of the Cancer Genetic Markers of Susceptibility (CGEMS) project. In 2007, he became the Chief of the newly formed Laboratory of Translational Genomics in the Division of Cancer Epidemiology and Genetics.
Other Links
